The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study.
Adolescent
Adult
Aged
COVID-19
/ epidemiology
COVID-19 Vaccines
/ administration & dosage
Female
Health Personnel
/ psychology
Humans
Influenza Vaccines
/ administration & dosage
Intention
Male
Middle Aged
Pandemics
Patient Acceptance of Health Care
/ psychology
State Medicine
United Kingdom
/ epidemiology
Vaccination
/ psychology
Young Adult
COVID
COVID-19
Health Service
National Health Service
Pandemic
United Kingdom
electronic health record
flu
impact
influenza
intention
observational
public health
uptake
vaccination
vaccine
virus
Journal
JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345
Informations de publication
Date de publication:
14 04 2021
14 04 2021
Historique:
received:
23
12
2020
accepted:
18
02
2021
revised:
07
02
2021
pubmed:
3
3
2021
medline:
21
4
2021
entrez:
2
3
2021
Statut:
epublish
Résumé
In the face of the COVID-19 pandemic, the UK National Health Service (NHS) extended eligibility for influenza vaccination this season to approximately 32.4 million people (48.8% of the population). Knowing the intended uptake of the vaccine will inform supply and public health messaging to maximize vaccination. The objective of this study was to measure the impact of the COVID-19 pandemic on the acceptance of influenza vaccination in the 2020-2021 season, specifically focusing on people who were previously eligible but routinely declined vaccination and newly eligible people. Intention to receive the influenza vaccine in 2020-2021 was asked of all registrants of the largest electronic personal health record in the NHS by a web-based questionnaire on July 31, 2020. Of those who were either newly or previously eligible but had not previously received an influenza vaccination, multivariable logistic regression and network diagrams were used to examine their reasons to undergo or decline vaccination. Among 6641 respondents, 945 (14.2%) were previously eligible but were not vaccinated; of these, 536 (56.7%) intended to receive an influenza vaccination in 2020-2021, as did 466 (68.6%) of the newly eligible respondents. Intention to receive the influenza vaccine was associated with increased age, index of multiple deprivation quintile, and considering oneself to be at high risk from COVID-19. Among those who were eligible but not intending to be vaccinated in 2020-2021, 164/543 (30.2%) gave reasons based on misinformation. Of the previously unvaccinated health care workers, 47/96 (49%) stated they would decline vaccination in 2020-2021. In this sample, COVID-19 has increased acceptance of influenza vaccination in previously eligible but unvaccinated people and has motivated substantial uptake in newly eligible people. This study is essential for informing resource planning and the need for effective messaging campaigns to address negative misconceptions, which is also necessary for COVID-19 vaccination programs.
Sections du résumé
BACKGROUND
In the face of the COVID-19 pandemic, the UK National Health Service (NHS) extended eligibility for influenza vaccination this season to approximately 32.4 million people (48.8% of the population). Knowing the intended uptake of the vaccine will inform supply and public health messaging to maximize vaccination.
OBJECTIVE
The objective of this study was to measure the impact of the COVID-19 pandemic on the acceptance of influenza vaccination in the 2020-2021 season, specifically focusing on people who were previously eligible but routinely declined vaccination and newly eligible people.
METHODS
Intention to receive the influenza vaccine in 2020-2021 was asked of all registrants of the largest electronic personal health record in the NHS by a web-based questionnaire on July 31, 2020. Of those who were either newly or previously eligible but had not previously received an influenza vaccination, multivariable logistic regression and network diagrams were used to examine their reasons to undergo or decline vaccination.
RESULTS
Among 6641 respondents, 945 (14.2%) were previously eligible but were not vaccinated; of these, 536 (56.7%) intended to receive an influenza vaccination in 2020-2021, as did 466 (68.6%) of the newly eligible respondents. Intention to receive the influenza vaccine was associated with increased age, index of multiple deprivation quintile, and considering oneself to be at high risk from COVID-19. Among those who were eligible but not intending to be vaccinated in 2020-2021, 164/543 (30.2%) gave reasons based on misinformation. Of the previously unvaccinated health care workers, 47/96 (49%) stated they would decline vaccination in 2020-2021.
CONCLUSIONS
In this sample, COVID-19 has increased acceptance of influenza vaccination in previously eligible but unvaccinated people and has motivated substantial uptake in newly eligible people. This study is essential for informing resource planning and the need for effective messaging campaigns to address negative misconceptions, which is also necessary for COVID-19 vaccination programs.
Identifiants
pubmed: 33651708
pii: v7i4e26734
doi: 10.2196/26734
pmc: PMC8048709
doi:
Substances chimiques
COVID-19 Vaccines
0
Influenza Vaccines
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26734Informations de copyright
©Patrik Bachtiger, Alexander Adamson, Ji-Jian Chow, Rupa Sisodia, Jennifer K Quint, Nicholas S Peters. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 14.04.2021.
Références
BMJ. 2020 Mar 23;368:m1170
pubmed: 32205309
Front Public Health. 2017 Mar 08;5:22
pubmed: 28337430
Psychol Sci. 2020 Jul;31(7):770-780
pubmed: 32603243
JAMA. 2010 Jan 20;303(3):271-2
pubmed: 20085957
Lancet. 2020 Jul 18;396(10245):e4-e5
pubmed: 32622374
Vaccine. 2012 Mar 23;30(14):2448-52
pubmed: 22300721
Health Technol Assess. 2001;5(31):1-256
pubmed: 11809125
Br J Gen Pract. 2020 Aug 27;70(698):450
pubmed: 32855134
J Public Health (Oxf). 2016 Dec 02;38(4):746-753
pubmed: 28158550
J Gen Intern Med. 2009 Dec;24(12):1311-3
pubmed: 19838758
Obesity (Silver Spring). 2020 Jun;28(6):1005
pubmed: 32237206
J Med Virol. 2021 Jan;93(1):64-65
pubmed: 32497290
Vaccine. 2011 Mar 16;29(13):2421-8
pubmed: 21277402
BMJ. 2020 Sep 23;370:m3720
pubmed: 32967850
BMJ. 2020 Jul 14;370:m2825
pubmed: 32665237
BMJ Open. 2012 May 11;2(3):
pubmed: 22581793
Trials. 2010 Jan 11;11:2
pubmed: 20064225
BMJ. 2020 Jun 23;369:m2514
pubmed: 32576551
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524